About The Section
Oncology
Publishes original research articles, letters, case reports, reviews/mini-reviews and guest edited thematic issues on various topics related to oncology.
The Oncology section of the journal Current Chinese Science publishes original research articles, letters, case reports, reviews/mini-reviews and guest edited thematic issues on various topics related to oncology.
This section is not limited to a specific aspect of the field but is instead devoted to a wide range of sub fields in the area. Articles of a multidisciplinary nature are particularly welcome. Submissions in the following areas are of special interest to the readers of this journal:
- Breast OncologyCancer
- Chemotherapy
- Experimental/Research Oncology
- Gastrointestinal Oncology
- Gynecologic Oncology
- Hematologic Oncology
- Hemato-Oncology
- Hormone therapy
- Immunotherapy
- Integrative oncology
- Interventional Oncology
- Medical Oncology
- Neuro-oncology
- Ocular Oncology
- Palliative care
- Pediatric Oncology
- Radiation Oncology
- Radiologist
- Surgery
- Surgical Oncology
- Targeted therapy
- Thyroid tumours
- Other related areas
Dr. Junmin Zhang is currently a full associate professor in the School of Pharmacy of Lanzhou University. He received his Ph.D. degree in Medicinal Chemistry & Biology (2017) from Lanzhou University. He then engaged in postdoctoral research at State Key Laboratory of Quality Research in Chinese Medicine of Macau University of Science and Technology, Macau (S.A.R.), China. He is a member of the Chinese Pharmacological Society and Chinese Chemical Society. His research interests focus on the discovery of small molecules targeting cellular redox systems or protein kinases as potential therapeutic agents and the elucidation of their pharmacodynamics and pharmacokinetic mechanism.
Dr. Haojie Jin received his Ph.D. degree from Medical College of Shanghai JiaoTong University. He was engaged as a postdoctoral fellow in the Nertherlands Cancer Institute in Amsterdam. Currently, he is a principal investigator of State Key Laboratory of Oncogenes and Related Genes, Shanghai JiaoTong University. His research interests mainly focus on using CRISPR-Cas9 functional genetic approaches to identify powerful drug combinations, new drug targets and mechanisms of resistance to cancer drugs. His major research work has been published in Nature (2019,2021), Gastroenterology, Cell Research, ACS Appl Mater Interfaces and Elife.
Section: Oncology
Current Status of Imaging Diagnosis and Treatment of Subcentimeter Hepatocellular Carcinoma
Volume: 3, Issue: 6
Pp: 408-419
Author: Peng Huang, Yuyao Xiao, Changwu Zhou, Fei Wu, Chun Yang* and Mengsu Zeng*
DOI: 10.2174/2210298103666230410104223
Published on: 02 May, 2023
Liquid Biopsy for Early Diagnosis of Hepatocellular Carcinoma: Current State and Future Perspectives
Volume: 3, Issue: 6
Pp: 420-443
Author: Huiqin Jiang, Wenjing Yang, Anli Jin, Hao Wang, Tong Li, Jingrong Xian, Wei Chen, Ling Ding, Beili Wang and Wei Guo*
DOI: 10.2174/2210298103666230410105139
Published on: 05 May, 2023
Current Diagnosis and Treatment for Hepatocellular Carcinoma with Macrovascular Tumor Thrombosis
Volume: 3, Issue: 6
Pp: 444-451
Author: Zhen-Hua Chen, Jin-Kai Feng, Zong-Han Liu, Kang Wang and Shu-Qun Cheng*
DOI: 10.2174/2210298103666230726163734
Published on: 31 August, 2023
Construction and Clinical Application of Digital Intelligent Diagnosis and Treatment System for Hepatocellular Carcinoma
Volume: 3, Issue: 6
Pp: 452-466
Author: Xiaojun Zeng, Haisu Tao, Wan Yee Lau* and Chihua Fang*
DOI: 10.2174/2210298103666230412082214
Published on: 05 May, 2023
Management of Hepatocellular Carcinoma: The East-West Difference
Volume: 3, Issue: 6
Pp: 467-476
Author: Maple Ye Feng and Stephen L. Chan*
DOI: 10.2174/2210298103666230912143208
Published on: 21 September, 2023